Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cardiome Pharma Corp (NASDAQ:CRME)

3.05
Delayed Data
As of 3:59pm ET
 +0.02 / +0.66%
Today’s Change
2.35
Today|||52-Week Range
6.36
+10.51%
Year-to-Date

Today’s Trading

Previous close3.03
Today’s open3.08
Day’s range2.98 - 3.08
Volume24,098
Average volume (3 months)57,141
Market cap$96.7M
Dividend yield--
Data as of 3:59pm ET, 03/22/2017

Growth & Valuation

Earnings growth (last year)+41.79%
Earnings growth (this year)+32.28%
Earnings growth (next 5 years)--
Revenue growth (last year)+20.78%
P/E ratio--
Price/Sales2.80
Price/Book2.84

Competitors

 Today’s
change
Today’s
% change
GEMPGemphire Therapeutic...+1.26+12.12%
CTRVContraVir Pharmaceut...-0.03-1.90%
EPIXESSA Pharma Inc+0.07+2.16%
RNNRexahn Pharmaceutica...+0.00+0.43%
Data as of 4:02pm ET, 03/22/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$25.3M
Annual profit (last year)-$19.6M
Net profit margin-77.68%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
William L. Hunter
Chief Operating Officer
Sheila M. Grant
Corporate headquarters
Vancouver, British Columbia

Forecasts


Search for Jobs